Insider Transactions in Q1 2021 at Tela Bio, Inc. (TELA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Nora Brennan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,928
+14.2%
|
-
|
|
Mar 31
2021
|
Peter C. Murphy Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,298
+14.55%
|
-
|
|
Mar 31
2021
|
Ellis Skott Greenhalgh Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,789
+10.07%
|
-
|
|
Mar 31
2021
|
Antony Koblish Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,439
+2.72%
|
-
|
|
Mar 26
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
37,851
+2.34%
|
$454,212
$12.88 P/Share
|
|
Mar 25
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.32%
|
$65,000
$13.11 P/Share
|
|
Mar 24
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,660
+0.17%
|
$34,580
$13.94 P/Share
|
|
Mar 23
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.65%
|
$130,000
$13.79 P/Share
|
|
Feb 24
2021
|
Peter C. Murphy Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,200
+50.0%
|
-
|
|
Feb 24
2021
|
Nora Brennan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+42.91%
|
-
|
|
Feb 24
2021
|
Maarten Persenaire Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+11.66%
|
-
|
|
Feb 24
2021
|
Ellis Skott Greenhalgh Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,600
+34.41%
|
-
|
|
Feb 24
2021
|
Antony Koblish Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,900
+15.59%
|
-
|
|
Feb 04
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,822
+0.18%
|
$39,508
$14.29 P/Share
|
|
Feb 02
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
250
+0.02%
|
$3,500
$14.08 P/Share
|
|
Feb 01
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,119
+0.07%
|
$15,666
$14.16 P/Share
|
|
Jan 29
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
7,760
+0.51%
|
$100,880
$13.93 P/Share
|
|
Jan 28
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
13,950
+0.91%
|
$181,350
$13.68 P/Share
|
|
Jan 27
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.33%
|
$70,000
$14.03 P/Share
|
|
Jan 26
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,544
+0.1%
|
$21,616
$14.24 P/Share
|
|
Jan 15
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
763
+0.05%
|
$9,919
$13.88 P/Share
|
|
Jan 14
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
9,075
+0.6%
|
$117,975
$13.96 P/Share
|
|
Jan 13
2021
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
7,002
+0.47%
|
$91,026
$13.9 P/Share
|